Last reviewed · How we verify
Shenbai Granules
Shenbai Granules is a Small molecule drug developed by Jiangsu Famous Medical Technology Co., Ltd.. It is currently in Phase 2 development. Also known as: placebo, Treatment group.
Shenbai Granules are a treatment being studied for preventing the recurrence of low-risk colorectal adenomas. They are being compared to a placebo in a multicenter randomized controlled clinical trial.
-
Baseline phase 2 → approval rate
+15.3pp
Industry-wide phase 2 drugs reach approval ~15.3% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2031–2034 | — |
| EMA | EU | 2032–2035 | +0.7 yr |
| MHRA | GB | 2032–2035 | +0.7 yr |
| Health Canada | CA | 2032–2036 | +0.9 yr |
| TGA | AU | 2032–2036 | +1.2 yr |
| PMDA | JP | 2032–2036 | +1.5 yr |
| NMPA | CN | 2033–2037 | +2.3 yr |
| MFDS | KR | 2032–2036 | +1.4 yr |
| CDSCO | IN | 2032–2037 | +1.8 yr |
| ANVISA | BR | 2033–2037 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | Shenbai Granules |
|---|---|
| Also known as | placebo, Treatment group |
| Sponsor | Jiangsu Famous Medical Technology Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Shenbai Granules for Preventing Malignant Transformation of High-risk Colorectal Adenomas (NA)
- Shenbai Granules for Preventing Recurrence of Low-Risk Colorectal Adenomas (NA)
- A Randomized Clinical Trial of Shenbai Granules in Reducing Recurrence of Colorectal Adenoma (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Shenbai Granules CI brief — competitive landscape report
- Shenbai Granules updates RSS · CI watch RSS
- Jiangsu Famous Medical Technology Co., Ltd. portfolio CI
Frequently asked questions about Shenbai Granules
What is Shenbai Granules?
Who makes Shenbai Granules?
Is Shenbai Granules also known as anything else?
What development phase is Shenbai Granules in?
Related
- Manufacturer: Jiangsu Famous Medical Technology Co., Ltd. — full pipeline
- Also known as: placebo, Treatment group
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing